Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05996419
Other study ID # D4401-P
Secondary ID 121RX004401-01-A
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 3, 2024
Est. completion date November 30, 2025

Study information

Verified date May 2024
Source VA Office of Research and Development
Contact Anouk L Grubaugh, PhD MA BS
Phone (843) 789-6664
Email Anouk.Grubaugh@va.gov
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Social anxiety is associated with significant deficits in social and occupational functioning. The proposed study seeks to evaluate the feasibility of implementing a brief text-based intervention for decreasing social anxiety related safety behaviors among Veterans attempting to re-integrate into the workforce. Findings from this pilot will support a larger randomized controlled study examining the efficacy of the intervention for improving functional outcomes and quality of life among Veterans.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date November 30, 2025
Est. primary completion date September 30, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Active enrollment in Compensated Work Therapy - Score of > 25 on the Social Phobia Inventory - Score of > 47 on the Subtle Avoidance Frequency Examination Exclusion Criteria: - Concurrent enrollment in another study related to social anxiety or improving functional status - Recent (<3 month) history of psychiatric hospitalization, detoxification admission, or suicide attempt

Study Design


Related Conditions & MeSH terms


Intervention

Other:
DSB-I
Participant will receive text message every other day during active phase (30days) via ANNIE text messaging app related to the safety behaviors they identified prior to start.

Locations

Country Name City State
United States Ralph H. Johnson VA Medical Center, Charleston, SC Charleston South Carolina

Sponsors (2)

Lead Sponsor Collaborator
VA Office of Research and Development Ralph H. Johnson VA Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other General Self-Efficacy Scale (GSE) 10-item self-report measure of self-efficacy. The GSE demonstrates adequate internal reliability and convergent and divergent validity. Items range from 1 to 4 with total scores ranging between 10 and 40 and higher scores indicative of more self-efficacy;, total mean score Baseline and immediately after intervention
Other PTSD Checklist (PCL-5) 20-item instrument that parallels DSM-5 criteria for PTSD. Each item has five response options. Scores range from 0-80 with higher scores indicative of PTSD. Measures DSM-5 criteria for PTSD Baseline and immediately after intervention
Other Patient Health Questionnaire (PHQ-9) a brief questionnaire that scores each of the 9 DSM-IV criteria for depression as "0" (not at all) to "3" (nearly every day). PHQ-9 score > or =10 have a sensitivity of 88% and a specificity of 88% for major depression. PHQ-9 scores of 5, 10, 15, and 20 represent mild, moderate, moderately severe, and severe depression, respectively , total mean score Baseline and immediately after intervention
Other Quality of Life Scale (QOL) 16-item self-report measure of quality of life across 5 conceptual domains: material and physical well-being, relationships with other people, social/community activities, personal development and fulfillment, and recreation, as well as an item on independence. The QOL demonstrates strong internal reliability and validity across medical populations and settings Baseline and immediately after intervention
Other Rate of recruitment Proportion of veterans who agree to participate compared to total number approached for enrollment 18 month (end of recruitment)
Other THE VETERANS RAND 12-ITEM HEALTH SURVEY (SF-12) valid and reliable instrument to measure quality of life/functional status in Veterans Baseline and immediately after intervention
Other Rate of retention Number of veterans who enroll and complete study procedures as well as follow up interview compared to number who enroll 18 month (end of recruitment)
Other Credibility and Expectancy Questionnaire (CEQ) will be used to assess the perceived credibility and expectancy related to effectiveness of the intervention. The CEQ will be administered only at baseline (following the intervention description), and 3 items from the measure will be used. These include: 1) how logical the program seems; 2) how successful the Veteran believes the program will be for him or her; and 3) how confident the Veteran would be recommending the program to a friend with similar needs. Baseline
Other Reactions to the Intervention This form consists of 3 questions comparable in scaling (i.e., using a 1 to 9 scale) to the CEQ. Specific questions target 1) satisfaction with the program; 2) likelihood of recommending the program to someone else; and 3) degree to which the Veteran believes the program helped with his or her difficulties and/or goals. immediately after intervention
Primary Subtle Avoidance Frequency Examination (SAFE) 32-item self-report measure designed to assess the frequency of safety behavior (SB) use. Respondents are asked to rate how often they engage in SBs such as "Rehearse sentences in your mind" and "Avoid eye contact" on a scale of 0 (Never) to 4 (Always). Scores on the SAFE range from 0-128 with higher scores indicative or more safety behavior use. total mean score Baseline and immediately after intervention
Primary Social Phobia Inventory (SPIN) 17-item measure of social anxiety severity. Participants are asked to rate items such as "I avoid doing things or speaking to people for fear of embarrassment" on a Likert-type scale of 0 (Not at all) to 4 (Extremely). Scores on the SPIN range from 0 to 68 with higher scores indicative of more severe social anxiety, total mean score baseline and immediately after intervention
See also
  Status Clinical Trial Phase
Completed NCT05168020 - Evaluation of a Self-Monitoring Intervention to Reduce Safety Behavior in Social Anxiety N/A
Not yet recruiting NCT06020170 - Delving Into Participation Patterns in Social Anxiety Studies
Completed NCT03297619 - Self-help Books for Social Anxiety N/A
Completed NCT04509531 - Building Resilience in Cyberbullying Victims N/A
Recruiting NCT04859790 - Acceptability/Feasibility Testing of SCAR N/A
Completed NCT05576259 - oVRcome - Self Guided Virtual Reality for Social Anxiety Disorder N/A
Completed NCT05858294 - The Safety, Acceptability and Efficacy of Alena N/A
Completed NCT04450303 - Social Anxiety Telehealth Therapy Study N/A
Completed NCT03601377 - Attention Bias Modification Treatment in Social Anxiety N/A
Completed NCT03671577 - Building Closer Friendships in Social Anxiety Disorder N/A
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Recruiting NCT05554718 - Evaluation of a Smartphone Application for Self-help for Social Anxiety N/A
Completed NCT02534948 - Feasibility Study of Mindfulness and Acceptance Based Group Therapy for Social Anxiety N/A
Completed NCT03249116 - Assessing Mechanisms of Anxiety Reduction in Animal-assisted Interventions N/A
Completed NCT05159037 - Using the Musical Track From GC-MRT as a Treatment Booster in Stressful Situations N/A
Completed NCT03711513 - Facing Fears by Focussing on Behaviour, Body, or Mind? N/A
Completed NCT04845100 - Animal Assisted Activities on the Stress and Social Anxiety N/A
Active, not recruiting NCT04276363 - Families, Children and Teachers Thriving Together N/A
Completed NCT05372744 - Affect-regulatory Characteristics of Deceptive Placebos N/A
Recruiting NCT05798078 - The Relationship Between Social Anxiety and Anxious Thinking Styles N/A